Reduced Leaflet Motion in Bioprosthetic Aortic Valves--The FDA Perspective
- PMID: 26437127
- DOI: 10.1056/NEJMp1512264
Reduced Leaflet Motion in Bioprosthetic Aortic Valves--The FDA Perspective
Comment on
-
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.N Engl J Med. 2015 Nov 19;373(21):2015-24. doi: 10.1056/NEJMoa1509233. Epub 2015 Oct 5. N Engl J Med. 2015. PMID: 26436963 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical